Table 1.

Demographic and clinical characteristics of the interviewees, and of the rest of the cohort

	Interviewees (N = 20)		Refused/no reaction (N = 57)		Total cohort (N = 108)
	N	%	N	%	N	%
Baseline characteristicsa
Age (M ± SD)	25 ± 9		25 ± 7		25 ± 7
Male	12	60	24	42	62	57
Unemployed/passive	5	25	10	17	24	22
Civil status, single	13	65	43	75	82	76
Living alone	5	25	20	35	38	35
Treatment group (inclusion years)b
API (1992–1993)	10	50	15	26	37	34
ODAP (1994–1997)	5	25	27	47	47	43
ODAP-II (2003–2005)	5	25	15	26	24	23
Diagnosis
Acute/transient	9	45	24	42	49	45
Schizophreniform	4	20	11	19	22	20
Schizophrenia	7	35	22	39	38	35
Antipsychotics in first year	7	35	11	19	22	20
Hospital admission in first year	12	60	24	42	43	40
Treatment during follow-upc
Hospital days (M ± SD)	100 ± 200		62 ± 123		63 ± 131
Hospital admissions (M ± SD)	4 ± 5		3 ± 4		3 ± 5
Antipsychotics	13	65	31	54	59	55
Characteristics at the time of the interviewc,d
Age (M ± SD)	45 ± 11		44 ± 9		45 ± 9
Disability allowance	8	40	18	32	32	33
Antipsychotics	7	35	18	32	32	33
Treatment contact	7	35	16	28	26	27

M mean, SD standard deviation, API Acute Psychosis Integrated study, ODAP Open Dialogue in Acute Psychosis study

^aMore detailed information on baseline characteristics, treatment groups, and diagnostic procedures are described elsewhere (Bergström, 2020)

^bInclusion period of three Open Dialogue research projects

^cData were gathered as part of long-term register-based follow-up (Bergström et al., 2018)

^dOnly people still alive at the end of the follow-up